TGA Approval

ADAKVEO crizanlizumab 10 mg/mL concentrate for solution for infusion vial (327317)

ARTG ID

327317

ARTG Name

ADAKVEO crizanlizumab 10 mg/mL concentrate for solution for infusion vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

April 8, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

Ingredient Name

crizanlizumab

Empowering clinical research with data-driven insights and AI-powered tools.

ADAKVEO crizanlizumab 10 mg/mL concentrate for solution for infusion vial (327317) - TGA 批准文号 | MedPath